Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09SZY
|
|||
| Former ID |
DIB016563
|
|||
| Drug Name |
IQ-DAA
|
|||
| Synonyms |
Anti-anthrax toxin mAb, IQ; Human monoclonal antibodies (anthrax), IQ; IQN-protective antigen (human mAb), IQ corporation; MAb-based immunotherapy (anthrax), IQ; IQNLF + IQNPA (human mAbs, Bacillus anthracis infection), IQ Therapeutics
Click to Show/Hide
|
|||
| Indication | Bacillus anthracis infection [ICD-11: 1G40] | Phase 1 | [1] | |
| Company |
IQ Therapeutics BV
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bacterial Lethal factor (Bact lef) | Target Info | Modulator | [2] |
| Bacterial Protective antigen (Bact pagA) | Target Info | Modulator | [2] | |
| Pathway Interaction Database | Cellular roles of Anthrax toxin | |||
| Reactome | Uptake and function of anthrax toxins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020942) | |||
| REF 2 | Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax.Future Microbiol.2009 Feb;4(1):35-43. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.